July, 2024 - neuropad

A study over 3 decades highlights the major role of metabolic control in the prevention of Diabetic Peripheral Neuropathy

25 Jul HbA1c and disease duration and the risk of developing peripheral neuropathy in type 1 diabetes

Posted at 11:18h in Blog

A recent study in Sweden has confirmed the prevalence of DPN in people with T1D with longer disease duration (over the course of 30 years). The authors were able to highlight the major role of metabolic control....

Diabetes UK report ... Cost of devastating complications highlights urgent need to transform diabetes care in the UK.

24 Jul Costs of diabetes in the UK estimated at £14 billion for 2021/22

Posted at 15:28h in Blog

The direct costs of diabetes in 2021/22 for the UK were estimated at £10.7 billion, of which just over 40% related to diagnosis and treatment, with the rest relating to the excess costs of complications. Indirect costs were estimated at £3.3 billion. A pragmatic review, commissioned by Diabetes UK and carried out by York Health Economics Consortium, shows that the NHS spends £10.7bn a year on diabetes, about 6% of the UK health budget. The review of relevant data sources for UK nations includes population-level data sets and published literature, to...

July 2024

25 Jul HbA1c and disease duration and the risk of developing peripheral neuropathy in type 1 diabetes

24 Jul Costs of diabetes in the UK estimated at £14 billion for 2021/22

Links